EQT related stories
All articles and analysis
EQT Life Sciences surpasses hard-cap to reach €260m for inaugural dementia fundThe life sciences unit increased its original €175m hard-cap to allow for more investment into the portfolio companies it seeks to back.
EQT to launch semi-liquid alts products in private wealth pushThe European giant aims to increase the share of private wealth capital in its closed-ended products, which stands at under 10%.
Extended fundraises: Will we see more of them in 2023?GPs are navigating the toughest fundraising and investment conditions since the 2008 financial crisis.
Fubon Life approves $129m in commitmentsThe Taiwan-based insurance company has backed two private equity funds.
More 'shadow processes', club deals in 2023 – WIPM SummitWith deal activity slowing, GPs are partnering up and ensuring that portfolio companies are agile and stress-tested, according to panellists from EQT, Eurazeo and Churchill Asset Management.
EQT raises €1.1bnThe third fund in the EQT Venture fund series has held a final close.
Currency volatility: A welcome tailwind for PE?Foreign exchange is too unpredictable to influence private equity decisions in the long run, but some portfolio companies could receive a boost from FX shifts in the near term.
EQT mulls bulking up private wealth offering in ‘competitive’ fundraising environmentThe Swedish firm is in market with its 10th flagship fund, which held a €15bn first close in August and has a target of €20bn.
OpEx Awards 22: Americas Large-cap winner – EQTEQT positioned biotechnology company Aldevron for continued growth by investing in new facilities, systems and mRNA and protein manufacturing capabilities.
EQT Growth I raises €2.2bnThe Stockholm-headquartered firm closed its first growth fund, based in Europe.